Association of overexpression of tumor suppressor protien p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

Journal of the National Cancer Institute

Volumn 84, Issue 14, 1992, Pages 1109-1114

  Isola, Jorma ^a   Visakorpi, Tapio ^b   Holli, Kaija ^b   Kallioniemi, Olli P ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST TUMOR; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; FEMALE; GENE EXPRESSION; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; PARAFFIN EMBEDDING; PROGNOSIS; PROTEIN P53; PROTO-ONCOGENE PROTEINS; RECEPTOR, ERBB-2; S PHASE; SURVIVAL ANALYSIS;

EID: 0026659891     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/84.14.1109     Document Type: Article

References (17)

1. McGuire WL, Tandon AK, Allred DC, ET al: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82:1006–1015, 1990
2. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453–456, 1991
3. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutations in human cancers. Science 235:49–53, 1991
4. Milner J, Medcalf EA, Cook AC: Tumor suppressor p53: Analysis of wild-type and mutant p53 complexes. Mol Cell Biol 11:12–19, 1991
5. Davidoff AM, Humphrey PA, Iglehart JD, et al: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5006–5010, 1991
6. Bártek J, Bártková J, Vojtéšek B, et al: Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699–1703, 1991
7. Ostrowskj JL, Sawan A, Henry L, et al: p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study. J Pathol 164:75–81, 1991
8. Davidoff AM, Herndon JE, Glover NS, et al: Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 110:259–264, 1991
9. Bloom HJ, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377, 1957
10. Kaluoniemi O-P, Holli K, Visakorpi T, et al: Association of c-erbB-2 protein overexpression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 49:650–655, 1991
11. Kallioniemi O-P, Visakorpi T, Paronen I, et al: A new algorithm to compensate for the effects of sliced nuclei on DNA histogram improves the prognostic impact of S-phase values from paraffin-embedded breast and prostatic carcinomas. Cytometry 12:413–421, 1991
12. Iwaya K, Tsuda H, Hiraide H, et al: Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 82:835–840, 1991
13. Thor AD, Moore DH, Edgerton SM, et al: Accumulation of p53 tumor suppressor gene protein is an independent marker of prognosis in breast cancer. J Natl Cancer Inst. In press
14. Cattoretti G, Rilke F, Andreola S, et al: p53 expression in breast cancer. Int J Cancer 41:178–183, 1988
15. Martinez J, Georgoff I, Martinez J, et al: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151–159, 1991
16. Chen L-C, Neubauer A, Kurisu W, et al: Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proc Natl Acad Sci USA 88:3847–3851, 1991
17. Borg Å, Baldetorp B, Fernö M, et al: ERBB2 amplification in breast cancer with high rate of proliferation. Oncogene 6:137–143, 1991